Cardiomyocytes are the sole source of cTnI and the main source of cTnT; hence, these assays have high biological specificity and are the only recommended biomarker for acute myocardial infarction (AMI) diagnosis in the Fourth Universal Definition of Myocardial Infarction [4]. This evidence concerns the gene TNNI3 and myocardial infarction.